Gilson Aaron M, Chladek Jason S, Stone Jamie A, Watterson Taylor L, Lehnbom Elin C, Hoffins Emily L, Berbakov Maria E, Moon Jukrin, Jacobson Nora A, Holden Richard J, Gangnon Ronald E, Walbrandt Pigarelli Denise L, Welch Lauren L, Portillo Edward C, Shiyanbola Olayinka O, Gollhardt Joel, Walker Kenneth, Chui Michelle A
From the Division of Social and Administrative Sciences.
Department of Pharmacy Systems, Outcomes, and Policy, University of Illinois Chicago College of Pharmacy, Chicago, Illinois.
J Patient Saf. 2025 Jan 1;21(1):38-47. doi: 10.1097/PTS.0000000000001288.
Older adults' (ages ≥65) inappropriate over-the-counter medications (OTC) use is prevalent, comprising Drug-Age, Drug-Drug, Drug-Disease, and Drug-Label types. Given that pharmacies sell many OTCs, structurally redesigning pharmacy aisles for improving patient safety (Senior Safe) was conceived to mitigate older adult OTC misuse, using Stop Signs and Behind-the-Counter Signs for high-risk OTCs. This study determined whether Senior Safe reduced high-risk OTCs misuse, while secondarily evaluating misuse changes for all OTCs.
A randomized controlled trial design matched and randomly allocated 20 health system community pharmacies to control or intervention groups. All 288 study participants completed an OTC choice task in which they chose a hypothetical symptom scenario (pain, sleep, cough/cold/allergy), selected an OTC, and described how they would use it at symptom onset and if symptoms persisted or worsened. Reported OTC use was evaluated for each misuse type. Intervention and control sites were compared for each misuse type using multivariate modeling.
For high-risk OTCs, Drug-Age and Drug-Drug misuse were more likely in control sites (OR = 2.752, P = 0.004; OR = 6.199, P = 0.003, respectively), whereas Drug-Disease and Drug-Label misuse had too few occurrences in intervention sites for statistical comparisons. For all OTCs, only Drug-Age misuse was more likely for control sites (OR = 5.120, P = 0.001). Adults aged 85+ years had the greatest likelihood of all misuse types.
Results demonstrated that older adults frequently reported multiple misuse types, highlighting safety concerns. Senior Safe reduced high-risk OTC misuse, especially for older adults younger than 85 years. Cumulatively, these findings provide insights into practice recommendations supported through regulatory guidance.
老年人(年龄≥65岁)非处方药物(OTC)使用不当的情况普遍存在,包括药物年龄、药物相互作用、药物疾病和药物标签等类型。鉴于药店销售多种非处方药,为提高患者安全性(老年人安全)而对药店过道进行结构重新设计的构想是,通过使用危险警示标志和柜台后标志来减少老年人非处方药的误用。本研究确定了“老年人安全”设计是否减少了高风险非处方药的误用,同时对所有非处方药的误用变化进行了二次评估。
采用随机对照试验设计,将20家卫生系统社区药店匹配并随机分配到对照组或干预组。所有288名研究参与者完成了一项非处方药选择任务,即他们选择一个假设的症状场景(疼痛、睡眠、咳嗽/感冒/过敏),选择一种非处方药,并描述他们在症状出现时以及症状持续或恶化时将如何使用该药物。对报告的每种误用类型的非处方药使用情况进行评估。使用多变量模型对干预组和对照组的每种误用类型进行比较。
对于高风险非处方药,对照组更有可能出现药物年龄和药物相互作用误用(分别为OR = 2.752,P = 0.004;OR = 6.199,P = 0.003),而干预组中药物疾病和药物标签误用的发生次数过少,无法进行统计比较。对于所有非处方药,只有对照组更有可能出现药物年龄误用(OR = 5.120,P = 0.001)。85岁及以上的成年人出现所有误用类型的可能性最大。
结果表明,老年人经常报告多种误用类型,突出了安全问题。“老年人安全”设计减少了高风险非处方药的误用,尤其是对于85岁以下的老年人。总体而言,这些发现为通过监管指导支持的实践建议提供了见解。